Liver Transplantation
📧 Sign up to get email alerts when something new happens for Liver Transplantation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-13FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) from Novartis. The approval expands its use for preventing orga…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Mycophenolic Acid submitted by Aurobindo Pharma Limited under an ANDA, approving changes to …
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (ONESOURCE SPECIALTY PHARMA LIMITED)
FDA approved a supplemental application for mycophenolate mofetil submitted by Onesource Specialty Pharma Limited. The action pertains to ch…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for mycophenolic acid, granting approval of the generic product under ANDA214630.…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel [NA]
This clinical trial update describes a pediatric liver fibrosis evaluation using a fibrosis panel in the context of liver transplantation, a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Evaluation of Pulmonary Complications in Liver Transplantation Patients Based on Machine Learning
A West China Hospital trial is recruiting to evaluate pulmonary complications in liver transplantation patients using machine learning techn…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation [NA]
This clinical trial update describes a study evaluating sequential hypo- and normothermic perfusion to preserve extended-criteria donor live…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: OCS Liver PROTECT Continued Access Protocol [NA]
This update reports the completion of the OCS Liver PROTECT Continued Access Protocol for liver transplant patients, with results posted.
-
FDA approval · 2024-07-08FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for mycophenolate mofetil from Concord Biotech Limited, enabling approval of a generic formulation u…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Envarsus Neurotoxicity Burden in Liver Transplant Patients [Phase 4]
Phase 4 trial update evaluating the neurotoxicity burden of Envarsus (tacrolimus extended-release) in liver transplant recipients; results p…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
A clinical trial evaluating intraoperative spectrometry to estimate liver graft steatosis during liver transplant surgery; currently recruit…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation
The trial update describes research and potential application of a new clinical diagnosis and treatment system for HBV-related hepatocellula…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Transportation Assistance Program for Liver Transplant [NA]
This clinical trial update describes a Transportation Assistance Program intended for liver transplant patients. Enrollment is by invitation…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A Study of Novel Biomarkers of Kidney Dysfunction at Liver Transplant
Completed clinical study evaluating novel biomarkers of kidney dysfunction in liver transplant patients.
-
FDA approval · 2024-05-01FDA Approved: MYHIBBIN — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approved MYHIBBIN, a mycophenolate mofetil product from Azurity Pharmaceuticals, under an original application (NDA216482). This approva…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Insulin Therapy for Postreperfusion Hyperglycemia [Phase 4]
Phase 4 clinical trial investigating insulin therapy for postreperfusion hyperglycemia in liver transplantation patients is currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Liver Immunosuppression Free Trial [Phase 4]
A Phase 4 clinical trial investigating liver transplantation immunosuppression was terminated.
-
FDA approval · 2024-02-27FDA Approved: MYCOPHENOLIC ACID — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for generic mycophenolic acid from Aurobindo Pharma Limited. It is indicated as part of an immunosuppr…
-
FDA approval · 2024-02-07FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic version of mycophenolate mofetil from Hikma Pharmaceuticals USA, enabling continue…
-
CLINICAL_TRIALS research · 2024-01-02Clinical Trial Update: Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations [Phase 4]
Phase 4 clinical trial comparing immediate-release versus extended-release tacrolimus and associated tremors in liver transplantation.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation. [Phase 4]
A Phase 4 clinical trial update exploring early conversion of prolonged-release tacrolimus in liver transplantation.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN) [Phase 4]
Phase 4 clinical trial evaluating mechanisms of hypertension treatments in liver transplant recipients has been withdrawn.
-
FDA approval · 2023-09-14FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for PROGRAF (tacrolimus) submitted by Astellas Pharma US, Inc.
-
FDA approval · 2023-09-14FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas, updating the labeling for its use as an immunosuppressant to…
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Bacillus Clausii in Liver Transplantation [Phase 2]
Phase 2 clinical trial update for Bacillus clausii in liver transplantation settings; status is unknown.